Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of application of growth hormone therapy and recombinant human growth hormone treatment in children with growth hormone deficiency.
In this webinar, the eminent speakers Prof. Michael B. Ranke, and Dr. Vaman Khadilkar has spoken on growth hormone therapy and recombinant human growth hormone treatment in children.
Growth hormone deficiency, also known as dwarfism or pituitary dwarfism. It is a condition when insufficient amounts of growth hormone is present in the body which causes the children to develop problems like abnormally short stature with normal body proportions.
The application of recombinant human growth hormone treatment can significantly improve the height of patients with ISS and GHD. Further, GH therapy can also be a safe and effective way to treat growth hormone deficiency, Turner Syndrome, and other conditions associated with short stature.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic
4.
The pandemic had little impact on mental health symptoms.
5.
How breast tissue density affects your risk of breast cancer
1.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
2.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
3.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
4.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
5.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation